S&P 500   4,443.11 (-0.28%)
DOW   34,869.37 (+0.21%)
QQQ   370.35 (-0.80%)
AAPL   145.37 (-1.05%)
MSFT   294.17 (-1.73%)
FB   353.58 (+0.18%)
GOOGL   2,821.44 (-0.80%)
TSLA   791.36 (+2.19%)
AMZN   3,405.80 (-0.58%)
NVDA   216.60 (-1.91%)
BABA   150.18 (+3.52%)
NIO   36.77 (+3.93%)
CGC   14.71 (+5.75%)
GE   105.35 (+1.49%)
MU   75.18 (+1.53%)
AMD   108.16 (+2.23%)
T   27.40 (+1.00%)
F   14.16 (+2.76%)
ACB   6.39 (+7.39%)
DIS   178.26 (+1.28%)
PFE   43.57 (-0.84%)
BA   224.16 (+1.25%)
AMC   39.30 (-1.77%)
S&P 500   4,443.11 (-0.28%)
DOW   34,869.37 (+0.21%)
QQQ   370.35 (-0.80%)
AAPL   145.37 (-1.05%)
MSFT   294.17 (-1.73%)
FB   353.58 (+0.18%)
GOOGL   2,821.44 (-0.80%)
TSLA   791.36 (+2.19%)
AMZN   3,405.80 (-0.58%)
NVDA   216.60 (-1.91%)
BABA   150.18 (+3.52%)
NIO   36.77 (+3.93%)
CGC   14.71 (+5.75%)
GE   105.35 (+1.49%)
MU   75.18 (+1.53%)
AMD   108.16 (+2.23%)
T   27.40 (+1.00%)
F   14.16 (+2.76%)
ACB   6.39 (+7.39%)
DIS   178.26 (+1.28%)
PFE   43.57 (-0.84%)
BA   224.16 (+1.25%)
AMC   39.30 (-1.77%)
S&P 500   4,443.11 (-0.28%)
DOW   34,869.37 (+0.21%)
QQQ   370.35 (-0.80%)
AAPL   145.37 (-1.05%)
MSFT   294.17 (-1.73%)
FB   353.58 (+0.18%)
GOOGL   2,821.44 (-0.80%)
TSLA   791.36 (+2.19%)
AMZN   3,405.80 (-0.58%)
NVDA   216.60 (-1.91%)
BABA   150.18 (+3.52%)
NIO   36.77 (+3.93%)
CGC   14.71 (+5.75%)
GE   105.35 (+1.49%)
MU   75.18 (+1.53%)
AMD   108.16 (+2.23%)
T   27.40 (+1.00%)
F   14.16 (+2.76%)
ACB   6.39 (+7.39%)
DIS   178.26 (+1.28%)
PFE   43.57 (-0.84%)
BA   224.16 (+1.25%)
AMC   39.30 (-1.77%)
S&P 500   4,443.11 (-0.28%)
DOW   34,869.37 (+0.21%)
QQQ   370.35 (-0.80%)
AAPL   145.37 (-1.05%)
MSFT   294.17 (-1.73%)
FB   353.58 (+0.18%)
GOOGL   2,821.44 (-0.80%)
TSLA   791.36 (+2.19%)
AMZN   3,405.80 (-0.58%)
NVDA   216.60 (-1.91%)
BABA   150.18 (+3.52%)
NIO   36.77 (+3.93%)
CGC   14.71 (+5.75%)
GE   105.35 (+1.49%)
MU   75.18 (+1.53%)
AMD   108.16 (+2.23%)
T   27.40 (+1.00%)
F   14.16 (+2.76%)
ACB   6.39 (+7.39%)
DIS   178.26 (+1.28%)
PFE   43.57 (-0.84%)
BA   224.16 (+1.25%)
AMC   39.30 (-1.77%)
BATS:ADME

Aptus Drawdown Managed Equity ETF Stock Forecast, Price & News

$40.55
-0.23 (-0.56 %)
(As of 09/27/2021 04:00 PM ET)
Add
Today's Range
$40.44
$40.65
50-Day Range
$39.70
$41.54
52-Week Range N/A
Volume17,080 shs
Average VolumeN/A
Market CapitalizationN/A
P/E RatioN/A
Dividend YieldN/A
BetaN/A
30 days | 90 days | 365 days | Advanced Chart
Receive ADME News and Ratings via Email

Sign-up to receive the latest news and ratings for Aptus Drawdown Managed Equity ETF and its competitors with MarketBeat's FREE daily newsletter.

Basic Details

Issuer Aptus Capital Advisors
Fund NameAptus Drawdown Managed Equity ETF
Tax ClassificationRegulated Investment Company
SymbolBATS:ADME
Inception Date6/8/2016
Fund ManagerJohn D. Gardner, Beckham D. Wyrick
WebN/A
PhoneN/A

Fund Focus

Asset ClassEquity
Benchmark
CategorySize and Style
FocusLarge Cap
Development LevelDeveloped Markets
RegionNorth America

Fund Statistics

Assets Under Management$278.46 million
Average Daily Volume$0.00
Discount/Premium0.02%

ETF Expenses

Management Fee0.79%
Other Expenses0.02%
Total Expenses0.81%
Fee Waiver0.00%
Net Expenses0.81%

Administrator, Advisor and Custodian

AdministratorU.S. Bancorp Fund Services, LLC
AdvisorAptus Capital Advisors, LLC
CustodianU.S. Bank, N.A.
DistributorQuasar Distributors, LLC
Transfer AgentU.S. Bank, N.A.
Trustee
Lead Market Maker

Geographic Exposure of ADME

Currency Exposure of ADME

Sector Exposure of ADME

Industry Exposure of ADME













Aptus Drawdown Managed Equity ETF (BATS:ADME) Frequently Asked Questions

What stocks does MarketBeat like better than Aptus Drawdown Managed Equity ETF?

Wall Street analysts have given Aptus Drawdown Managed Equity ETF a "N/A" rating, but there may be better buying opportunities in the stock market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new stock ideas, but Aptus Drawdown Managed Equity ETF wasn't one of them. MarketBeat thinks these five companies may be even better buys.
View MarketBeat's top stock picks here.

How has Aptus Drawdown Managed Equity ETF's stock price been impacted by Coronavirus?

Aptus Drawdown Managed Equity ETF's stock was trading at $29.47 on March 11th, 2020 when Coronavirus reached pandemic status according to the World Health Organization. Since then, ADME stock has increased by 37.6% and is now trading at $40.55.
View which stocks have been most impacted by COVID-19
.

What is Aptus Drawdown Managed Equity ETF's stock symbol?

Aptus Drawdown Managed Equity ETF trades on the BATS under the ticker symbol "ADME."

Who are Aptus Drawdown Managed Equity ETF's major shareholders?

Aptus Drawdown Managed Equity ETF's stock is owned by a number of retail and institutional investors. Top institutional shareholders include Formidable Asset Management LLC (0.00%), Sigma Planning Corp (0.00%) and Patriot Financial Group Insurance Agency LLC (0.00%).

Which major investors are selling Aptus Drawdown Managed Equity ETF stock?

ADME stock was sold by a variety of institutional investors in the last quarter, including Formidable Asset Management LLC, and Patriot Financial Group Insurance Agency LLC.

Which major investors are buying Aptus Drawdown Managed Equity ETF stock?

ADME stock was bought by a variety of institutional investors in the last quarter, including Sigma Planning Corp.

How do I buy shares of Aptus Drawdown Managed Equity ETF?

Shares of ADME can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Aptus Drawdown Managed Equity ETF's stock price today?

One share of ADME stock can currently be purchased for approximately $40.55.


This page was last updated on 9/27/2021 by MarketBeat.com Staff

Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.